Monday, October 6, 2014

Top Long Term Stocks For 2014

Sirius XM (NASDAQ:SIRI), the biggest satellite-radio provider in the U.S., has been on a tear since the end of the financial crisis. After trading at as low as 6 cents in February 2009, the stock now trades 57 times higher at a price of $3.48. Can Sirius sustain its dominance in the satellite radio space in the long term? Let�� use our CHEAT SHEET investing framework to decide whether Sirius is an OUTPERFORM, WAIT AND SEE, or STAY AWAY.

C = Catalysts for the Stock�� Movement

Sirius�� subscriber base grew a record 9 percent in 2012. The radio service has added around 5 million subscribers since 2008, mostly coming from new vehicle sales. Revenues increased 12 percent in the first quarter to $897.4 million. It is no surprise that Sirius profits from increased auto sales ��about two-thirds of new cars come with a trial of Sirius, of which an estimated 45 percent of drivers choose to subscribe full-time. Last month, Ford�(NYSE:F) announced a 13 percent gain in revenue, and analysts estimate that new auto sales will hit 15.5 million this year; but if vehicle sales slow this year, so too will Sirius�� subscriber growth. Investors interested in Sirius should pay special attention to monthly auto sales data.

10 Best Financial Stocks For 2015: Axiall Corp (AXLL)

Axiall Corporation (Axiall), formerly Georgia Gulf Corporation, incorporated on April 16, 1984, is a manufacturer and an international marketer of chlorovinyl and aromatic chemicals and also manufacture and market vinyl-based building and home improvement products. The Company operates in three business segments: Chlorovinyls segment consists of two product groups: Electrovinyls products, which are composed of chlorine, caustic soda, ethylene dichloride (EDC), vinyl chloride monomer (VCM), and vinyl resins; and Compound products, which are composed of vinyl compounds, compound additives and plasticizers; Building Products segment consists of two primary product groups: Window and Door Profiles and Mouldings, and Outdoor Building Products, which consists of siding, pipe and pipe fittings and deck, fence and rail products, and Aromatics segment also contains two commodity chemical product groups: cumene; and phenol and acetone. In January 2013, the combined company formed by uniting Georgia Gulf with PPG's former commodity chemicals business is named Axiall Corporation.

Chlorovinyls segment

The chlorovinyls segment consists of an integrated chain of products, which including chlor-alkali and derivative products (chlorine, caustic soda, vinyl chloride monomer (VCM), vinyl resins, ethylene dichloride, chlorinated solvents, calcium hypochlorite, hydrochloric acid and phosgene derivatives and compound products (vinyl compounds and compound additives and plasticizers). In North America, the Company is one of the producers of VCM, vinyl resins, and vinyl compounds.

During the year ended December 31, 2012, approximately 45%t of its vinyl resins production was sold into the United States and Canadian merchant markets where its vinyl resins were used in a variety of flexible and rigid vinyl end-use applications. During 2012, the largest end-uses of its products were for pipe and pipe fittings, siding, extruded sheet and film and window profiles. Approximately 24% of its pro! duction was sold into the export market, and approximately 31% of its vinyl resins were used internally in the manufacture of its vinyl compounds and vinyl building products. During 2012, the Company used substantially all of its VCM production in the manufacture of vinyl resins in its PVC manufacturing operations. The Company sells all of its caustic soda to customers domestically and overseas in numerous industries, with the pulp and paper, chemical and alumina industries constituting its markets. Other markets for its caustic soda include soap and detergents and the water treatment industries.

Vinyl compounds are highly customized formulations that offer specific end-use properties based on customer-determined manufacturing specifications that enable its customers to utilize them directly in their manufacturing processes to fabricate their finished products. The Company produces flexible and rigid compounds, which are used in many different applications, including wire and cable insulation and jacketing, electrical outlet boxes and pipe fittings, window and furniture profiles and food-grade and general-purpose bottles. It also supplies chlorinated vinyl compounds (CPVC), to the extrusion and injection molding markets, mainly for production of hot water pipe and pipe fittings. The Company produces lubricants, stabilizers, impact modifiers and process aids used in the production of compounds, and which are part of the typical compound formulations. The majority of its additives and plasticizers are consumed internally.

Building Products Segment

The Window and Door Profiles and Mouldings Products have a level of customization based on customer specifications, whereas Outdoor Building Products are based more on industry standards. The Company manufactures and extrude vinyl window profiles, including frames, sashes, trim and other components, as well as vinyl patio door components and fabricated patio doors, which are sold primarily to window and door fabricators. I! ts sales ! are primarily to the custom segment of the vinyl window profile market with the profile design customized to a window fabricator's specific requirements. It manufactures and markets extruded decorative mouldings and millwork. Its decorative trim products are used for interior mouldings, such as crown, base and chair rail. For exterior mouldings, its products are used in applications, such as brick mouldings, and as components used in the fabrication of doors, windows and spas. This product line includes a series of offerings, such as bendable trim and paintable/stainable trim.

The Company�� outdoor building products (OBP) include siding; pipe and pipe fittings; and deck, fence, and rail. It manufactures vinyl siding, and it also offers a range of accessories, including vinyl soffit, aluminum soffit, fascia and trim and molded vent mounts and exterior shutters. These additional product offerings to its existing offerings include rich, dark, color-fast shades, as well as a siding system, which enables siding panels to withstand harsh wind conditions. It manufactures pipe and pipe fittings for the municipal and electrical markets, as well as pipe for plumbing applications. Its municipal pipe and pipe fittings product lines are used in potable water applications, as well as in storm and sewer applications. Its plumbing lines are used in residential and industrial applications to move storm and sanitary wastewater from the building to the municipal sewer at the property line. This product line is focused on at drain, waste and vent applications. Electrical, pipe, conduit and fittings are available in a range of sizes and configurations, to meet the needs of both commercial and residential applications.

The Company manufactures vinyl deck products that are sold by distributors and used primarily by professionally installed market segments. The Company�� deck product lines are positioned as a lower-maintenance alternative to conventional wood products.

Aromatics Seg! ment

The aromatics segment is integrated and consists of cumene and phenol/acetone products. Phenol/acetone products are co-products made from cumene in the same production process. The Company�� aromatic products are primarily commodity based products. It operates cumene plant located in Pasadena, Texas. About 28 % of its cumene was consumed internally, during 2012, to produce phenol and acetone. Cumene is used as an intermediate to make phenol and acetone and specialty chemicals and can be sold as an additive for gasoline blending.

Phenol is sold to a base of customers who are producers of a range of phenolic resins, engineering plastics and specialty chemicals. Phenolic resins are used as adhesives for wood products, such as plywood and Oriented Strand Board (OSB). Engineering plastics are used in compact discs, digital video discs, automobiles, household appliances, electronics and protective coating applications. It also sells phenol for use in insulation, electrical parts, oil additives and chemical intermediates. Acetone is a chemical used primarily in the production of acrylic resins, engineering plastics and industrial solvents. The Company sells the majority of its acetone into the acrylic resins market, where it is used in the manufacture of various plastics and coatings used for signage, automotive parts, household appliances, paints and industrial coatings. Other uses range from solvents for automotive and industrial applications to pharmaceuticals and cosmetics.

Advisors' Opinion:
  • [By Johanna Bennett]

    Dow isn�� the only chemical play gaining on the news. �Axiall (AXLL) rose 9.3% to $49.58 in Monday market action. Olin (OLN) rose 6.1% to $26.36. And Westlake Chemical (WLK) rose 2.2% to $115.10.

  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    In trading on Thursday, basic materials shares were relative leaders, up on the day by about 1.20 percent. Among the leading sector stocks, gains came from Axiall (NYSE: AXLL), Materion (NYSE: MTRN), Huntsman (NYSE: HUN) and Joy Global (NYSE: JOY).

Top Long Term Stocks For 2014: Home Loan Servicing Solutions Ltd (HLSS)

Home Loan Servicing Solutions, Ltd, incorporated on December 1, 2010, is a development-stage company. The Company is formed to acquire mortgage servicing assets, primarily subprime and Alt-A mortgage servicing rights and associated servicing advances. The Company will engage residential mortgage loan servicers to service the pools of mortgage loans underlying the mortgage servicing rights. The Company acquire and therefore do not intend to develop its own mortgage servicing platform.

The Company is focused to enter into the subservicing agreement to provide for the servicing of the initial mortgage servicing rights for an initial term of seven years. As of December 31, 2010, The Company had neither purchased nor contracted to purchase any mortgage servicing assets, including mortgage servicing rights and related servicing advances.

Advisors' Opinion:
  • [By David Sterman]

    Although shares of Boulder Brands (Nasdaq: BDBD) are up more than 60% since then, Home Loan Servicing (Nasdaq: HLSS) has merely treaded water while Swift Energy has continued its downward ascent.

  • [By Eric Volkman]

    Home Loan Servicing Solutions (NASDAQ: HLSS  ) is servicing its capital base with a new share offering that should total nearly $300 million. The company is floating 13 million shares of its stock in an underwritten public issue at a price of $23 per share. All told, the gross proceeds of the offering should amount to roughly $299 million.

Top Long Term Stocks For 2014: Magellan Health Services Inc.(MGLN)

Magellan Health Services, Inc. engages in the specialty managed healthcare business in the United States. The company, through its contracted network of third-party treatment providers, offers managed behavioral healthcare services, including outpatient programs, such as counseling or therapy; intermediate care programs comprising intensive outpatient programs and partial hospitalization services; and inpatient treatment and crisis intervention services. It also provides radiology benefits management services, such as the delivery of diagnostic imaging and other therapeutic services through contracts with health plans and insurance companies, and governmental agencies. In addition, the company offers specialty pharmaceutical management services, including contracting and formulary optimization programs; specialty pharmaceutical dispensing operations; and medical pharmacy management programs. Its specialty pharmaceutical management services are provided under contracts with health plans, insurance companies, employers, and governmental agencies to manage specialty drugs used in the treatment of conditions, such as cancer, multiple sclerosis, hemophilia, infertility, rheumatoid arthritis, chronic forms of hepatitis, and other diseases. Further, the company provides Medicaid administration services comprising pharmacy point-of-sale claims processing systems and administration, drug utilization review, clinical prior authorization, utilization and formulary management services, preferred drug list programs, maximum allowable cost programs, and drug rebate program services under contracts with health plans and public sector healthcare clients for Medicaid and other program recipients. It serves health plans, insurance companies, employers, labor unions, and various governmental agencies. Magellan Health Services, Inc. was founded in 1969 and is based in Avon, Connecticut.

Advisors' Opinion:
  • [By Susan J. Aluise]

    Although Medicaid has far slimmer margins than other business lines, MOH has the expertise to gain volume as enrollees grow. It also has a strong Medicaid franchise in two key states: California and Washington. MOH has a price to earnings growth (PEG) ratio of only 0.8, suggesting that the stock could be undervalued. It also has a forward P/E of 14, lower than many other healthcare stocks.

    Healthcare Stocks: Magellan Health Services (MGLN)

    Magellan Health Services (MGLN) recently rebranded its business lines into three distinct units. The company’s behavior health affiliates, along with integrated health business Magellan Complete Care, are branded under the Magellan Healthcare business. Magellan Rx Management focuses on Magellan’s pharmacy business. And the specialty solutions business is now branded under NIA Magellan.

  • [By Lauren Pollock]

    Magellan Health Services(MGLN), which manages public-sector pharmacy benefits programs and other health-care services, offered a preliminary earnings forecast for next year that badly missed Wall Street expectations as share repurchases and the effect of the Affordable Care Act tax are seen hurting the bottom line, while its revenue estimate was stronger than expected.

  • [By Jake L'Ecuyer]

    Magellan Health Services (NASDAQ: MGLN) shares tumbled 3.53 percent to $58.98 after the company reported a 50% drop in its fourth-quarter earnings.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Magellan Health Services (Nasdaq: MGLN  ) , whose recent revenue and earnings are plotted below.

Top Long Term Stocks For 2014: Enanta Pharmaceuticals Inc (ENTA)

Enanta Pharmaceuticals, Inc., incorporated on July 25, 1995, is a research and development-focused biotechnology company. The Company uses its chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field. The Company is discovering and developing novel inhibitors designed for use against the hepatitis C virus (HCV). These inhibitors include members of the direct acting antiviral (DAA) inhibitor classes-protease (partnered with AbbVie, the former research-based pharmaceutical business of Abbott Laboratories), NS5A (partnered with Novartis) and nucleotide polymerase, as well as a host targeted antiviral (HTA) inhibitor class targeted against cyclophilin. ABT-450, discovered through its collaboration with AbbVie, is a protease inhibitor that has demonstrated in vitro potency against known resistant HCV mutants.

In Phase I studies, ABT-450 co-administered with ritonavir, a commonly used boosting agent to increase the blood concentrations of many protease inhibitors, was shown to be safe and well tolerated. Co-administration of ABT-450 with ritonavir, which it refers to together as ABT-450/r, has enabled once-daily dosing of ABT-450. Phase II studies have demonstrated the efficacy of ABT-450/r in patients with chronic HCV, and other interferon-free Phase II studies of ABT-450-containing regimens continue. AbbVie is developing a next-generation protease inhibitor discovered within the Enanta-AbbVie collaboration. EDP-239 is the NS5A inhibitor discovered by the Company. The Company also has a program to develop nucleotide inhibitors to HCV NS5B polymerase, which is another DAA mechanism considered to have a barrier to resistance. The Company�� Bicyclolide antibiotic product candidate is EDP-788, which it is developing for use as an intravenous drug in the hospital setting and for oral dosing in the home setting. EDP-788 is a prodrug, which means that it is inactive until it is converted in the body into an active compound. EDP-788 is! a water-soluble molecule which, when administered in preclinical models, is cleanly and rapidly converted into the active compound.

Advisors' Opinion:
  • [By Sean Williams]

    The next big thing in treating hepatitis-C
    The other currently experimental therapy very likely to make it onto the FDA's desk before the midpoint of 2014 is AbbVie's (NYSE: ABBV  ) direct-acting antiviral combo drug. In similar fashion to Sovaldi, this DAA-combo therapy, which includes ABT-450 from Enanta Pharmaceuticals (NASDAQ: ENTA  ) , is running six confirmatory late-stage trials on various genotypes. There are, however, two primary differences between AbbVie's DAA-combo therapy and Sovaldi.

  • [By James Fink]

    And lastly I'll go into healthcare, which is kind of a growth cyclical type name. It's partially defensive, partially growth. I think the more growth-oriented section of healthcare would be biotech, and right now, a very promising biotech stock is Enanta Pharmaceuticals. That's a NASDAQ stock; ticker symbol (ENTA).

  • [By George Budwell]

    Normally, such strong efficacy results would be hailed as a major achievement. However, these results are actually less impressive than those by competing drug's developed by AbbVie (NYSE: ABBV  ) , Enanta Pharmaceuticals (NASDAQ: ENTA  ) and Gilead. Bristol-Myers' therapy also has a treatment duration double that of Gilead's drug Sovaldi for genotype 1 patients. So, while these results are impressive in their own right, the therapy's commercial prospects may be limited due to the presence of superior competitors in the market.�

Top Long Term Stocks For 2014: MedCAREERS Group Inc (MCGI)

MedCareers Group, Inc., incorporated on December 30, 2004, focus is to develop and build value through its wholly owned subsidiary Nurses Lounge (www.nurseslounge.com), an online professional network and communication source for nurses and organizations connected to the nursing community. On August 10, 2010, MedCareers acquired the workabroad.com Website from Steve Elisberg (Workabroad.com Website).

The Nurses Lounge is a professional network for nursing professionals providing relevant content and information and professional networking. Nurses can subscribe to Lounges created by nursing schools, nurse associations, employers, specialties and more to receive email updates of relevant news, events and other info. Professional networking is a place for nurses to connect with colleagues and network on a professional level.

Advisors' Opinion:
  • [By Peter Graham]

    Last Friday, small cap stocks MedCAREERS Group Inc (OTCMKTS: MCGI), USmart Mobile Device Inc (OTCMKTS: UMDI) and Drinks Americas Holdings, Ltd (OTCMKTS: DKAM) were all over the place with the first two sinking 54% and 48.05%, respectively, while the last one rose 10.81%. It should be mentioned that all three small cap stocks have been the subject of paid promotions albeit none of these stocks have been over promoted. So where can investors and traders expect these stocks to head this week? Here is a quick look at what you might expect:

    MedCAREERS Group Inc (OTCMKTS: MCGI) Gets Additional Commitments to Join Its Subsidiary

    Small cap MedCAREERS Group aims to develop and build value through its wholly-owned subsidiary Nurses Lounge, Inc., an online professional network and communication source for nurses that offers a 21st century solution to recruitment and information that cannot be accomplished on a static nursing school or association website. On Friday, MedCAREERS Group sank 54% to $0.0575 for a market cap of $3.03 million plus MCGI is up 161.4% since the start of the year and down 93.9% over the past five years according to Google Finance.

  • [By Peter Graham]

    While small cap green or renewable energy type of stocks have been the flavor of the month for many stock promoters (and sometimes still are), small cap health care stocks like PPJ Enterprise (OTCMKTS: PPJE), Plantation Development Corp (OTCMKTS: BRMA) and MedCAREERS Group Inc (OTCMKTS: MCGI) have also started to get some notice lately ��perhaps because Obamacare has been topping the news lately. However, are these small cap health care stocks a better bet for investors or for their promoters? Here is a quick reality check and a checkup:

Top Long Term Stocks For 2014: Super Micro Computer Inc.(SMCI)

Super Micro Computer, Inc., together with its subsidiaries, develops and provides high performance server solutions based on modular and open-standard architecture. The company offers a range of rackmount, workstation, storage, graphic processing unit, and blade server systems, as well as subsystems and accessories used by distributors, original equipment manufacturers, and end customers to assemble server systems. It provides server options with single, dual, and quad CPU capability supporting Intel Pentium and Xeon multi-core architectures; and server systems based on AMD dual and quad Opteron. The company also offers server subsystems and accessories, including server boards, and chassis and power supplies. In addition, it sells other system accessories, such as microprocessors, memory, and disc drives. The company sells its server systems, and server subsystems and accessories through distributors, including value added resellers, system integrators, and original equip ment manufacturers, as well as through its direct sales force primarily in the United States, Europe, and Asia. Super Micro Computer, Inc. was founded in 1993 and is headquartered in San Jose, California.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Super Micro Computer (NASDAQ: SMCI) shares were also up, gaining 11.50 percent to $21.13 after the company reported upbeat FQ3 results and issued a strong Q4 forecast.

No comments:

Post a Comment